Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nick’s in connection with 100 MUSD funding round
Mandate

Vinge has advised Nick’s in connection with 100 MUSD funding round

October 29, 2021

Vinge has advised the food-tech brand Nick’s, which offers sugar free ice cream and snacks, in connection with their largest funding round to date.

The Company raised USD 100 million in a funding round led by investment company Kinnevik. Temasek, Ambrosia Investments, Gullspång Invest, Peak Bridge, Capagro and Nicoya also participated in the funding round, alongside other existing shareholders.

The Nick’s brand was launched four years ago and is today present in 16 markets. On the US market alone, Nick’s products are available in appr. 6,700 stores. The new funding will primarily be used to strengthen Nick’s growth in Europe and North America.

Vinge’s team consisted of Daniel Rosvall, Maria Dahlin Kolvik, Jonathan Riddersholm and Ebba Nyberg.

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026